期刊文献+

脂质体介导的huIFN-β基因转染对胶质瘤细胞侵袭力抑制作用研究

Inhibitory effects of liposome-mediated gene transfer of interferon-β on invasive potential of human glioma cells in vitro
下载PDF
导出
摘要 目的探讨人β-干扰素(huIFN-β)基因脂质体pSV2IFN-β对人脑胶质瘤细胞体外侵袭力的抑制作用。方法用含huIFN-β基因的脂质体体外转染人脑胶质瘤细胞系SHG44,用Western blot和细胞免疫荧光染色法检测目的基因的蛋白表达。通过Boyden小室法检测SHG44转染前后细胞体外侵袭力的变化,同时采用明胶酶谱法分析基质金属蛋白酶2(MMP-2)和基质金属蛋白酶9(MMP-9)的比活性。结果转染pSV2IFN-β后,SHG44细胞中的目的基因蛋白有显著表达;磷酸盐缓冲液(PBS)对照组、空载体转染组、pSV2IFN-β脂质体转染组的侵袭性细胞数分别为49.26±14.67、54.63±12.27和18.17±5.42,转染靶基因后SHG44细胞的体外侵袭力受到明显抑制,这与MMPs活性下降的改变相一致。结论转染huIFN-β基因脂质体pSV2IFN-β使脑胶质瘤细胞系SHG44的侵袭力受到明显抑制,提示脂质体介导的huIFN-β基因治疗可能是抗神经胶质瘤侵袭的一个有效的方法。 Objective To evaluate the effects of liposorne-mediated gene transfer of human interferon-β (hulFN-β)on invasion of human glioma cell line SHG44 in vitro. Method SHG44 cells were transfected with pSV2IFN-β in vitro. The protein expression of hulFN-β was detected with Western blotting and immunofluorescence staining respectively. The relative activity of matrix rnetalloproteinases-2 (MMP-2) and matrix rnetalloproteinases-9 (MMP-9)was determined by gelatin zymogram, and the invasion of SHG 44 in vitro was observed using Boyden chamber. Results The protein expression of hulFN-β increased significantly when SHG 44 cells were transfected with pSV2IFN-β. The number of invasion cells of PBS control group, SHG 44 infected with empty liposome and pSV2IFN-β was 49.26 +_ 14. 67, 54. 63 +_ 12. 27 and 18. 17 + 5.42 respectively. In vitro invasion of glioma cells was significantly inhibited after infected with pSV2IFN-β, and it was consistent with the decline change in MMPs activity. Conclusion The invasion of glioma cells is inhibited significantly after transfection of pSV2IFN-β. These results imply that liposome-mediated gene tmnffer of huIFN-β may be useful for anti-invasion therapy of malignant glioma.
出处 《中华神经外科疾病研究杂志》 CAS 2007年第5期428-431,共4页 Chinese Journal of Neurosurgical Disease Research
基金 国家自然科学基金资助项目(39970752)
关键词 Β-干扰素 脂质体 胶质瘤细胞 侵袭性 Interferon-β Liposome Glioma cell Invasion
  • 相关文献

参考文献12

  • 1王忠诚.王忠诚神经外科学[M].武汉:湖北科学技术出版社,2004.475.
  • 2Davies B, Miles DW, Happerfield LC, et al. Activity of type Ⅳ collagenases in benign and malignant breast disease [J]. Br J Cancer, 1993, 67(5) : 1126 -1131.
  • 3Groves MD, Puduvalli VK, Hess KR, et al. Phase Ⅱ trial of temozolomide plus the matrix metallopmteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme[ J ]. J Clin Oncol, 2002, 20(5) : 1383 - 1388.
  • 4Albini A, Iwamoto Y, Kleinman HK, et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells [ J ]. Cancer Res, 1987, 47(12) : 3239 -3245.
  • 5Yoshida J, Mizuno M. Clinical gene therapy for brain tumors. Liposomal delivery of anticancer molecule to glioma [ J ]. J Neurooncol, 2003, 65(3) : 261 -267.
  • 6Kageshita T, Mizuno M, Ono T, et al. Growth inhibition of human malignant melanoma transfected with the human interferon-beta gene by means of cationic liposomes [J]. Melanoma Res, 2001, 11 (4) : 337 - 342.
  • 7Uhl M, Weiler M, Wick W, et al. Migratory neural stem cells for improved thymidine kinase-based gene therapy of malignant gliomas [ J]. Biochem Biophys Res Commun, 2005, 328 (1) : 125 -129.
  • 8Bellail AC, Hunter SB, Brat DJ, et al. Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion [J]. Int J Biochem Cell Biol, 2004, 36(6) : 1046 -1069.
  • 9Planchenauh T, Costa S, Fages C, et al. Differential expression of laminin and fibronectin and of their related metalloproteinases in human glioma cell lines: relation to invasion [J]. Neurosci Lett, 2001, 299 (1): 140 - 144.
  • 10Lu W, Zhou X, Hong B, et al. Suppression of invasion in human U87 glioma cells by adenovirus-mediated co-transfer of TIMP-2 and PTEN gene? [J]. Cancer Lett, 2004, 214(2) : 205 -213.

二级参考文献18

  • 1Blankenstein T, Qin Z. The role of IFN-gamma in tumor transplantation immunity and inhibition of chemical carcinogenesis[J]. Curr Opin Immunol, 2003;15(2):148-154.
  • 2VanDeusen JB, Caligiuri MA. New developments in anti-tumor efficacy and malignant transformation of human natural killer cells[J]. Curr Opin Hematol, 2003;10(1):55-59.
  • 3Nakanishi H,Mizutani Y,Kawauchi A,et al. Significant antitumoral activity of cationic multilamellar liposomes containing human IFN-beta gene against human renal cell carcinoma [J]. Clin Cancer Res, 2003;9(3):1129-1135.
  • 4Yoshida J,Mizuno M,Nakahara N,et al. Antitumor effect of an adeno-associated virus vector containing the human interferon-beta gene on experimental intracranial human glioma [J]. Jpn J Cancer Res, 2002;93(2):223-228.
  • 5Kageshita T, Mizuno M, Ono T. Growth inhibition of human malignant melanoma transfected with the human interferon-β gene by means of cationic liposomes[J]. Melanoma Res, 2001;11(4):337-342.
  • 6Takaoka T, Yoshida J, Mizuno M, et al. Transfection-induced tumor necrosis factor-alpha increases the susceptibility of human glioma cells to lysis by lymphokine-activated killer cells: continuous expression of intercellular adhesion molecule-1 on the gli
  • 7Sangfelt O, Erickson S, Castro J, et al. Induction of apoptosis and inhibition of cell growth are independent responses to interferon-alpha in hematopoietic cell lines [J]. Cell Growth Differ, 1997, 8(2): 343-352.
  • 8Mizuno M, Yoshida J, Sugita K, et al. Reinforced cytotoxicity of lymphokine-activated killer cells toward glioma cells by transfection of the killer cells with the gamma-interferon gene [J]. Jpn J Cancer Res, 1995, 86(1): 95-100.
  • 9Rep MH, Schrijver HM, van Lopik T, et al. Interferon (IFN)-beta treatment enhances CD95 and interleukin 10 expression but reduces interferon-gamma producing T cells in MS patients [J]. J Neuroimmunol, 1999, 96(1): 92-100.
  • 10Yoshida J, Mizuno M, Yagi K. Efficient transfection of human interferon-beta gene to human glioma cells by means of cationic multilamellar liposomes coupled with a monoclonal antibody [J]. J Neurooncol, 1994, 19(9): 269-274.

共引文献192

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部